Members |
targetComponentId |
([D]Glucose blood level abnorm) or (hyperglycaemia &/or [drug induced]) |
Drug-induced hyperglycemia (disorder) |
([D]Glucose blood level abnorm) or (hyperglycaemia &/or [drug induced]) |
Hyperglycemia |
([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) |
Sleep apnea |
([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) |
Breathing-related sleep disorder |
([D]Hypersomnia with sleep apnoea) or (sleep apnoea syndrome) |
Hypersomnia with sleep apnea |
([HIV] or [AIDS] risk lifestyle) or (multiple sexual partners) |
HIV risk lifestyle |
([HIV] or [AIDS] risk lifestyle) or (multiple sexual partners) |
Multiple sexual contacts |
([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) |
Polyglandular autoimmune syndrome, type 2 |
([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) |
Disorder of endocrine system |
([Lloyd's] or [Schmidt's] syndrome) or (other combinations of endocrine dysfunction) |
Autoimmune polyendocrinopathy |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Patient asked to attend |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Follow-up consultation |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Provider-initiated encounter |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Provider-initiated encounter |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Patient asked to attend |
([Provider initiated encounter] or [patient asked to come in]) or (follow-up consultation) |
Follow-up consultation |
([Thyrotoxicosis] or [hyperthyroidism]) or (toxic goitre) |
Toxic goiter |
([Tiredness] or [fatigue] or [lethargy] or [malaise] symptom) or (C/O "muzzy head") |
Tired |
([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous detachment |
([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous detachment |
([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous opacities (disorder) |
([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous floaters |
([Vitreous floaters] &/or [opacities]) or (vitreous detachment) |
Vitreous floaters |
.21 inch caliber bullet, device |
Bullet |
.22 inch caliber bullet, device |
Bullet |
.25 inch caliber bullet, device |
Bullet |
.270 inch caliber bullet, device |
Bullet |
.28 inch caliber bullet, device |
Bullet |
.30 inch caliber bullet, device |
Bullet |
.303 inch caliber bullet, device |
Bullet |
.32 inch caliber bullet, device |
Bullet |
.338 inch caliber bullet, device |
Bullet |
.35 inch caliber bullet, device |
Bullet |
.375 inch caliber bullet, device |
Bullet |
.38 inch caliber bullet, device |
Bullet |
.40 inch caliber bullet, device |
Bullet |
.41 inch caliber bullet, device |
Bullet |
.44 inch caliber bullet, device |
Bullet |
.45 inch caliber bullet, device |
Bullet |
.50 inch caliber bullet, device |
Bullet |
.55 inch caliber bullet, device |
Bullet |
.60 inch caliber bullet, device |
Bullet |
0 Buck shot, device |
Shot size |
0 Buck shot, device |
Shotgun shot |
00 Buck shot, device |
Shotgun shot |
00 Buck shot, device |
Shot size |
1 Buck shot, device |
Shotgun shot |
1 Buck shot, device |
Shot size |
1-Naphthalene measurement |
Naphthalene measurement |
10 mm caliber bullet, device |
Bullet |
10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
10-30% body burnt |
Burn any degree involving 10-19 percent of body surface |
10-30% body burnt |
Burn any degree involving 30-39 percent of body surface |
10-30% body burnt |
Burn any degree involving 20-29 percent of body surface |
11-hydroxyetiocholanolone |
11-hydroxyandrosterone (substance) |
15 year examination |
Child 15 year examination (procedure) |
15 year examination |
Child 15 year examination (procedure) |
15 year examination |
Child 15 year examination (procedure) |
16-dehydroprogesterone hydratase |
16-alpha-hydroxyprogesterone dehydratase |
17-Beta-estriol |
Estradiol |
18-Hydroxydeoxycortisol measurement |
18-Hydroxycortisol measurement |
1q partial trisomy syndrome |
Partial trisomy of long arm of chromosome 1 (disorder) |
1q partial trisomy syndrome |
Trisomy 1q syndrome (disorder) |
2,2-Dichloro-1,1-difluoroethylmethyl ether |
Methoxyflurane |
2-Thio,4-Carboxythiazolidine |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid |
2-Thio,4-carboxythiazolidine measurement |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid measurement (procedure) |
21q partial trisomy syndrome |
21q partial distal trisomy (disorder) |
21q partial trisomy syndrome |
21q partial trisomy (disorder) |
22q11 microdeletion with complete DiGeorge sequence |
22q11.2 deletion syndrome (disorder) |
24 hour urine volume (& level) |
24 hour urine sample volume measurement |
24 hour urine volume (& level) |
24 hour urine volume - finding |
3 Buck shot, device |
Shot size |
3 Buck shot, device |
Shotgun shot |
3 day faecal fat estimation (& level) |
3 day faecal fat estimation |
3,4 Methylhippurate |
Para-methyl hippurate (substance) |
3,4-Methylhippurate measurement |
para-Methyl hippurate measurement (procedure) |
3-Hydroxybutylcarnitine |
3-hydroxybutyrylcarnitine (substance) |
3-Hydroxybutylcarnitine measurement |
3-hydroxybutyrylcarnitine measurement |
3-tree-Pharmacia pollen mix |
Tree pollen (substance) |
3-tree-Pharmacia pollen mix allergen |
Tree pollen (substance) |
3/4 crown |
Crown |
30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
4 Buck shot, device |
Shotgun shot |
4 Buck shot, device |
Shot size |
4,5-Dihydroxyhexanolactone |
4,5-dihydroxyhexanoate (substance) |
4-Allylmethoxy-2-phenol |
Eugenol |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
Hawkinsinuria (disorder) |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
4-Hydroxyphenylpyruvate dioxygenase deficiency (disorder) |
4-Hydroxyphenylpyruvate dioxygenase deficiency |
Tyrosinemia type III (disorder) |
4-quinolones overdose |
Quinolone antibacterial overdose |
4-quinolones overdose of undetermined intent |
Quinolone antibacterial overdose |
4-quinolones poisoning |
Fluoroquinolone poisoning (disorder) |
4-quinolones poisoning of undetermined intent |
Fluoroquinolone poisoning (disorder) |
5-OH indole acetic acid (& level (& urine)) |
5-hydroxyindole acetic acid (substance) |